With special thanks to Hans Kaspersetz from our AI sponsor Arteric who kindly shares this blog post. Hans will be presenting at our forthcoming 2020 BioPharma eMarketing Summit this coming May 5-7 2020 in San Diego, CA. Structured Data Will Help You Engage With...
We always overestimate the change that will occur in the next two years and underestimate the change that will occur in the next 10.- Bill GatesGrowth opportunities are hard to come by without significant investment, but one major opportunity is a self-running engine...
With special thanks to Hans Kaspersetz from Arteric who kindly shares this blog post. Hans will be presenting and chairing at our forthcoming (and currently in production) 2020 BioPharma eMarketing Summit on May 5-7 2020 in San Diego. We’re aggressively preparing our...
Controlled delivery formulations remain one of the favored tools for advancing the lifecycle of pharmaceutical products. A traditional strategy is to initially launch multiple daily doses of an immediate-release (IR) product, then reformulate into a once-daily...
There are a number of pharmacological and economical benefits to developing controlled and modified release drug products. Following the 505(b)(2) pathway allows companies to make modest changes to an already approved drug and get continued market exclusivity for a...
Recent Comments